| Date | Form | Description | Docs | XBRL | Pages |
| 03/13/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 09/07/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
33 |
| 06/11/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 03/09/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 09/08/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/26/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
32 |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 08/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/20/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 02/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
Latest News & Events
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology
Read More...Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference
Read More...Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Read More...